MDxHealth S.A.
MDXH | NASDAQ
$0.60
$0 (0.00%)
Sep 22, 2026, 2:16 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 107.88M | 90.05M | 70.19M | 37.05M | 22.24M | 18.46M |
Cost of Revenue | 43.43M | 34.91M | 26.26M | 17.84M | 11.68M | 10.42M |
Gross Profit | 64.44M | 55.14M | 43.93M | 19.22M | 10.56M | 8.04M |
Operating Income | -15.4M | -24.72M | -27.33M | -37.9M | -26.84M | -27.12M |
Interest Income | 1.5M | 1.08M | 1.09M | 125K | 11K | 4K |
Pretax Income | -35.38M | -37.69M | -43.1M | -44.04M | -29M | -28.66M |
Net Income | -33.52M | -38.07M | -43.1M | -44.04M | -29M | -28.66M |
Selling & General & Admin | 66.75M | 61.4M | 59.93M | 50.12M | 30.22M | 28.61M |
Research & Development | 10.35M | 10.55M | 6.38M | 7.56M | 5.59M | 4.54M |
Other Expenses | 2.74M | 7.92M | 4.96M | -559K | 1.6M | 2.01M |
Operating Expenses | 79.84M | 79.86M | 71.26M | 57.12M | 37.41M | 35.17M |
Interest Expense | 12.16M | 7.63M | 5.77M | 2.74M | 1.88M | 1.54M |
Selling & Marketing Expenses | 7.77M | 6.44M | 36.92M | 26.58M | 3.02M | 2.81M |
Cost & Expenses | 123.28M | 114.77M | 97.52M | 74.95M | 49.08M | 45.58M |
Income Tax Expense | -1.86M | 382K | 1K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 50.03M | 48.67M | 25.91M | 15.87M | 12.19M | 8.32M |
Shares Outstanding (Diluted) | 50.03M | 48.67M | 25.91M | 15.87M | 12.19M | 8.32M |
EPS (Basic) | -0.67 | -0.78 | -1.66 | -2.78 | -2.38 | -3.44 |
EPS (Diluted) | -0.67 | -1.16 | -1.66 | -2.78 | -2.38 | -3.44 |
EBITDA | -14.01M | -22.02M | -30.47M | -36.39M | -24.09M | -23.98M |
EBIT | -23.22M | -30.06M | -37.33M | -41.3M | -27.13M | -27.31M |
Depreciation & Amortization | 9.21M | 8.04M | 6.86M | 4.91M | 3.04M | 3.33M |
Add to Watchlist
Select watchlists to add or remove MDXH